UBS positive on, page-11

Quite a long article at six columns around the need to keep investing in science, and teaching a STEM curriculum in schools.

.....the data on mRNA vaccines is very positive .....governments the world over are reviewing their local manufacturing capability....for some years Sequirus has been developing next generation self-amplifying technology - beyond the vaccines we see today....human clinical trials due next year...

He says CSL will need to scale up any new production facilities as the Australian market is too small.

Looking for some government $$$ I would say.